Neutralizing antibody patterns and viral escape in HIV-1 non-B subtype chronically infected treatment-naive individuals

Halonna R. Kelly, Mateusz Urbanski, Sherri Burda, Ping Zhong, Frank Konings, Joseph Nanfack, Marcel Tongo, Thompson Kinge, Jacqueline M. Achkar, Phillipe Nyambi

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Here we studied the patterns of generation of neutralizing antibodies (NAbs) and virus escape during non-B subtype HIV-1 chronic infection among asymptomatic patients, and established whether a correlation exists between the generation of NAbs and the kinetics of CD4 T-cell decline. Therefore, sequential viruses and plasma obtained at 6 months to one year intervals over a three years period from ten HIV-1 group M subtype A, CRF02_AG, G, and H infected treatment-naïve individuals were tested in neutralization assays. Overall, NAbs were present in all ten individuals, and had the capacity to neutralize autologous virus obtained six months earlier. Eight of the ten subjects showed an increasing capacity to neutralize early viruses and a low capacity to neutralize contemporaneous and later time-point viruses. The neutralizing activities within these individuals resulted in emergence of neutralization resistant viruses, and with the subsequent generation of more NAbs to the emerging resistant viruses. In the remaining two individuals, the capacity to neutralize early, contemporaneous, and later time-point viruses remained conserved. While the kinetics of CD4 T-cell decline varied among all ten individuals, there was no correlation with the capacity to generate NAbs in that, sequential plasmas from individuals with moderately or rapidly declining CD4 T-cells were capable of neutralizing early sequential viruses. We conclude from this study that in non-B subtype chronically infected asymptomatic patients with moderately and rapidly declining CD4 T-cells, potent NAbs are readily generated as the virus evolves to escape the effect of these antibodies.

Original languageEnglish (US)
Pages (from-to)89-99
Number of pages11
JournalHuman Antibodies
Volume14
Issue number3-4
StatePublished - 2005
Externally publishedYes

Fingerprint

Neutralizing Antibodies
HIV-1
Viruses
T-Lymphocytes
Therapeutics
Asymptomatic Infections
Antibodies

Keywords

  • CD4 T-cell decline
  • Chronic infection
  • Neutralizing antibodies
  • Non-B HIV-1

ASJC Scopus subject areas

  • Immunology

Cite this

Kelly, H. R., Urbanski, M., Burda, S., Zhong, P., Konings, F., Nanfack, J., ... Nyambi, P. (2005). Neutralizing antibody patterns and viral escape in HIV-1 non-B subtype chronically infected treatment-naive individuals. Human Antibodies, 14(3-4), 89-99.

Neutralizing antibody patterns and viral escape in HIV-1 non-B subtype chronically infected treatment-naive individuals. / Kelly, Halonna R.; Urbanski, Mateusz; Burda, Sherri; Zhong, Ping; Konings, Frank; Nanfack, Joseph; Tongo, Marcel; Kinge, Thompson; Achkar, Jacqueline M.; Nyambi, Phillipe.

In: Human Antibodies, Vol. 14, No. 3-4, 2005, p. 89-99.

Research output: Contribution to journalArticle

Kelly, HR, Urbanski, M, Burda, S, Zhong, P, Konings, F, Nanfack, J, Tongo, M, Kinge, T, Achkar, JM & Nyambi, P 2005, 'Neutralizing antibody patterns and viral escape in HIV-1 non-B subtype chronically infected treatment-naive individuals', Human Antibodies, vol. 14, no. 3-4, pp. 89-99.
Kelly HR, Urbanski M, Burda S, Zhong P, Konings F, Nanfack J et al. Neutralizing antibody patterns and viral escape in HIV-1 non-B subtype chronically infected treatment-naive individuals. Human Antibodies. 2005;14(3-4):89-99.
Kelly, Halonna R. ; Urbanski, Mateusz ; Burda, Sherri ; Zhong, Ping ; Konings, Frank ; Nanfack, Joseph ; Tongo, Marcel ; Kinge, Thompson ; Achkar, Jacqueline M. ; Nyambi, Phillipe. / Neutralizing antibody patterns and viral escape in HIV-1 non-B subtype chronically infected treatment-naive individuals. In: Human Antibodies. 2005 ; Vol. 14, No. 3-4. pp. 89-99.
@article{dbbb0c457de2424e98703d108f45e48a,
title = "Neutralizing antibody patterns and viral escape in HIV-1 non-B subtype chronically infected treatment-naive individuals",
abstract = "Here we studied the patterns of generation of neutralizing antibodies (NAbs) and virus escape during non-B subtype HIV-1 chronic infection among asymptomatic patients, and established whether a correlation exists between the generation of NAbs and the kinetics of CD4 T-cell decline. Therefore, sequential viruses and plasma obtained at 6 months to one year intervals over a three years period from ten HIV-1 group M subtype A, CRF02_AG, G, and H infected treatment-na{\"i}ve individuals were tested in neutralization assays. Overall, NAbs were present in all ten individuals, and had the capacity to neutralize autologous virus obtained six months earlier. Eight of the ten subjects showed an increasing capacity to neutralize early viruses and a low capacity to neutralize contemporaneous and later time-point viruses. The neutralizing activities within these individuals resulted in emergence of neutralization resistant viruses, and with the subsequent generation of more NAbs to the emerging resistant viruses. In the remaining two individuals, the capacity to neutralize early, contemporaneous, and later time-point viruses remained conserved. While the kinetics of CD4 T-cell decline varied among all ten individuals, there was no correlation with the capacity to generate NAbs in that, sequential plasmas from individuals with moderately or rapidly declining CD4 T-cells were capable of neutralizing early sequential viruses. We conclude from this study that in non-B subtype chronically infected asymptomatic patients with moderately and rapidly declining CD4 T-cells, potent NAbs are readily generated as the virus evolves to escape the effect of these antibodies.",
keywords = "CD4 T-cell decline, Chronic infection, Neutralizing antibodies, Non-B HIV-1",
author = "Kelly, {Halonna R.} and Mateusz Urbanski and Sherri Burda and Ping Zhong and Frank Konings and Joseph Nanfack and Marcel Tongo and Thompson Kinge and Achkar, {Jacqueline M.} and Phillipe Nyambi",
year = "2005",
language = "English (US)",
volume = "14",
pages = "89--99",
journal = "Human Antibodies",
issn = "1093-2607",
publisher = "IOS Press",
number = "3-4",

}

TY - JOUR

T1 - Neutralizing antibody patterns and viral escape in HIV-1 non-B subtype chronically infected treatment-naive individuals

AU - Kelly, Halonna R.

AU - Urbanski, Mateusz

AU - Burda, Sherri

AU - Zhong, Ping

AU - Konings, Frank

AU - Nanfack, Joseph

AU - Tongo, Marcel

AU - Kinge, Thompson

AU - Achkar, Jacqueline M.

AU - Nyambi, Phillipe

PY - 2005

Y1 - 2005

N2 - Here we studied the patterns of generation of neutralizing antibodies (NAbs) and virus escape during non-B subtype HIV-1 chronic infection among asymptomatic patients, and established whether a correlation exists between the generation of NAbs and the kinetics of CD4 T-cell decline. Therefore, sequential viruses and plasma obtained at 6 months to one year intervals over a three years period from ten HIV-1 group M subtype A, CRF02_AG, G, and H infected treatment-naïve individuals were tested in neutralization assays. Overall, NAbs were present in all ten individuals, and had the capacity to neutralize autologous virus obtained six months earlier. Eight of the ten subjects showed an increasing capacity to neutralize early viruses and a low capacity to neutralize contemporaneous and later time-point viruses. The neutralizing activities within these individuals resulted in emergence of neutralization resistant viruses, and with the subsequent generation of more NAbs to the emerging resistant viruses. In the remaining two individuals, the capacity to neutralize early, contemporaneous, and later time-point viruses remained conserved. While the kinetics of CD4 T-cell decline varied among all ten individuals, there was no correlation with the capacity to generate NAbs in that, sequential plasmas from individuals with moderately or rapidly declining CD4 T-cells were capable of neutralizing early sequential viruses. We conclude from this study that in non-B subtype chronically infected asymptomatic patients with moderately and rapidly declining CD4 T-cells, potent NAbs are readily generated as the virus evolves to escape the effect of these antibodies.

AB - Here we studied the patterns of generation of neutralizing antibodies (NAbs) and virus escape during non-B subtype HIV-1 chronic infection among asymptomatic patients, and established whether a correlation exists between the generation of NAbs and the kinetics of CD4 T-cell decline. Therefore, sequential viruses and plasma obtained at 6 months to one year intervals over a three years period from ten HIV-1 group M subtype A, CRF02_AG, G, and H infected treatment-naïve individuals were tested in neutralization assays. Overall, NAbs were present in all ten individuals, and had the capacity to neutralize autologous virus obtained six months earlier. Eight of the ten subjects showed an increasing capacity to neutralize early viruses and a low capacity to neutralize contemporaneous and later time-point viruses. The neutralizing activities within these individuals resulted in emergence of neutralization resistant viruses, and with the subsequent generation of more NAbs to the emerging resistant viruses. In the remaining two individuals, the capacity to neutralize early, contemporaneous, and later time-point viruses remained conserved. While the kinetics of CD4 T-cell decline varied among all ten individuals, there was no correlation with the capacity to generate NAbs in that, sequential plasmas from individuals with moderately or rapidly declining CD4 T-cells were capable of neutralizing early sequential viruses. We conclude from this study that in non-B subtype chronically infected asymptomatic patients with moderately and rapidly declining CD4 T-cells, potent NAbs are readily generated as the virus evolves to escape the effect of these antibodies.

KW - CD4 T-cell decline

KW - Chronic infection

KW - Neutralizing antibodies

KW - Non-B HIV-1

UR - http://www.scopus.com/inward/record.url?scp=33646716040&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646716040&partnerID=8YFLogxK

M3 - Article

C2 - 16720979

AN - SCOPUS:33646716040

VL - 14

SP - 89

EP - 99

JO - Human Antibodies

JF - Human Antibodies

SN - 1093-2607

IS - 3-4

ER -